FDA's Readiness Questioned In Electronic AER Comments
This article was originally published in The Tan Sheet
Executive Summary
FDA's planned move to mandatory electronic filing of adverse event reports is raising concerns about costs for small businesses and the agency's ability to fully integrate its growing number of electronic filing requirementsYou may also be interested in...
CHPA comments on OTCs in AER submission rule
Final Guidance For Reporting Adverse Events Gets Serious On Definitions
People In Brief
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: